NCT06179069 2026-04-03
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
Zai Lab (Hong Kong), Ltd.
Phase 1 Recruiting
Clinical Trials
17 trialsNCT07110103 2026-02-27
JACKPOT38
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT07416695 2026-02-18
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC
Shanghai Henlius Biotech
Phase 1 Not yet recruiting
NCT06021483 2025-09-16
Observational Study to Evaluate the Safety and Efficacy of Zepzelcaâ„¢ Injection
Boryung Pharmaceutical Co., Ltd
Recruiting
NCT07145333 2025-09-08
Drug-SNP
Medicine Invention Design, Inc
Phase 2/3 Active not recruiting
NCT05844150 2025-03-12
A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC
Biotheus Inc.
Phase 2 Active not recruiting
NCT06820762 2025-02-11
Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study
The Second Affiliated Hospital of Dalian Medical University
Phase 2 Not yet recruiting
NCT06616532 2024-12-19
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
Biotheus Inc.
Phase 3 Recruiting
NCT05879068 2024-12-18
A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC
Biotheus Inc.
Phase 2 Active not recruiting
NCT06475209 2024-06-26
Adebrelimab + Apatinib in SCLC Maintenance Therapy
Tang-Du Hospital
Phase 2 Recruiting
NCT04750239 2023-08-14
Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer
Y-mAbs Therapeutics
Phase 1/2 Terminated
NCT05026593 2023-07-19
A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Completed
NCT04677361 2021-10-08
Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab
Fox Chase Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT02990780 2021-04-28
Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC
Shanghai Chest Hospital
Phase 3 Unknown
NCT03428607 2021-02-18
Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]
Samsung Medical Center
Phase 2 Completed
NCT04684017 2020-12-24
Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer
Shanghai Chest Hospital
Phase 2 Unknown
NCT03244904 2017-08-10
Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment
Fujian Cancer Hospital
Unknown